Literature
首页医源资料库在线期刊美国临床营养学杂志2003年78卷第4期

Suggested lower cutoffs of serum zinc concentrations for assessing zinc status: reanalysis of the second National Health and Nutrition Examination Survey data

来源:《美国临床营养学杂志》
摘要:ABSTRACTBackground:Theriskofzincdeficiencyinpopulationscanbeestimatedbycomparingserumzincdatawithstatisticallydefinedlowercutoffsderivedfromapresumablyhealthypopulation。SerumzincdataareavailablefromalargesampleoftheUSpopulationassessedduringthesecondNa......

点击显示 收起

Christine Hotz, Janet M Peerson and Kenneth H Brown

1 From the Centro de Investigación en Nutrición y Salud, Instituto Nacional de Salud Pública, Cuernavaca, Mexico (CH), and the Program in International Nutrition, University of California, Davis (JMP and KHB).

2 Supported by the International Zinc Nutrition Consultative Group, the International Zinc Association, and the International Maternal and Child Health and Nutrition Training Center sponsored by the Fogarty International Center of the US National Institutes of Health (grant 1 D43 TW01267-01).

Correspondence: 3 Reprints not available. Address correspondence to KH Brown, Program in International Nutrition, University of California, Davis, One Shields Avenue, Davis, CA 95616. E-mail: khbrown{at}ucdavis.edu.


ABSTRACT  
Background: The risk of zinc deficiency in populations can be estimated by comparing serum zinc data with statistically defined lower cutoffs derived from a presumably healthy population. Serum zinc data are available from a large sample of the US population assessed during the second National Health and Nutrition Examination Survey (NHANES II). Although the original analysis of these data considered fasting status and the time of day of blood sampling, it did not account for potentially confounding variables that may affect the serum zinc concentration, such as age, sex, and health status.

Objective: The objective was to describe variations in serum zinc concentration by age, sex, and other characteristics and to recommend lower cutoffs for presumably healthy persons.

Design: Serum zinc data from NHANES II were analyzed by using analysis of variance and covariance models to identify and describe variables significantly associated with serum zinc concentration; 2.5th percentile curves were produced and used to establish age- and sex-based lower cutoffs.

Results: Age and sex were significant confounders of serum zinc concentration, so separate lower cutoffs were derived for children and adolescent and adult males and females. Other minor confounding variables were identified. Tentative lower cutoffs for pregnancy and oral contraceptive use were also derived.

Conclusions: The interpretation of population serum zinc data with the use of lower cutoffs should account for the age and sex of the subjects, pregnancy and oral contraceptive use, and fasting status and time of day of blood collection.

Key Words: Serum zinc • zinc deficiency • second National Health and Nutrition Examination Survey • NHANES II


INTRODUCTION  
In recent decades, a large amount of information has accumulated about the possible widespread occurrence of zinc deficiency (1) and the various associated health consequences, which include growth faltering (2); an increased prevalence of infections (3) and impaired neurobehavioral function in children (4, 5); poor pregnancy outcomes, such as impaired fetal development (6, 7) and infant health (8); and reduced immunocompetence in the elderly (9). This information indicates an urgent need to assess the prevalence of zinc deficiency in representative samples of at-risk populations with the use of direct indicators of zinc status.

Currently, the serum or plasma zinc concentration is the most widely used biochemical indicator of zinc status and is the only biochemical indicator of zinc status for which adequate reference data are available. Although serum or plasma zinc is not considered to be a reliable indicator of zinc status in individual persons, a growing body of evidence suggests that it may be a useful indicator of a population’s zinc status (6, 10, 11). The second National Health and Nutrition Examination Survey (NHANES II) of the United States (1976–1980) included serum zinc concentration in its biochemical assessments. The analysis of these data led to the derivation of cutoffs for low serum zinc concentrations (12), which have been used since to assess zinc status. Separate cutoffs were derived on the basis of the fasting state and the time of day of sample collection. It is apparent, however, that the serum zinc concentration also varies with age and sex (12) and health status (13), so the use of a single cutoff for all age and sex groups may not be appropriate.

Thus, the objectives of the current study were to reanalyze the NHANES II data to 1) describe the variation in serum zinc concentration according to age, sex, and other characteristics (eg, health and physiologic status) in addition to the time of day of sample collection and the fasting status of the subjects; 2) assess the appropriateness of the currently used cutoffs for serum zinc concentration, and 3) present new recommendations for appropriate cutoffs, as necessary.


SUBJECTS AND METHODS  
NHANES II was a nationwide survey of 27 801 people between 6 mo and 74 y of age that was conducted in the United States between 1976 and 1980. Information was collected on current and past health status, health-related behaviors, presence of medical conditions, use of medications, dietary intakes, stature, and a variety of biochemical indicators. Details of the survey design, methodology, data collected, and procedures for blood preparation and laboratory analyses were reported previously (14, 15). Questionnaires used in the survey, survey data, and variable codes were downloaded from the Internet (http://www.cdc.gov/nchs/about/major/nhanes/nhanesii.htm; October, 2000).

Blood samples were successfully collected from 17 797 of 18 549 participants aged =" BORDER="0"> 3 y; serum zinc concentrations for 14 770 participants were available for the analysis. Certain groups were deliberately oversampled in the survey; thus, it was necessary to apply sample weighting factors to reflect the actual means and prevalences for the US population subgroups. Serum zinc data were log transformed before the analysis to yield a more symmetrical distribution.

In the first phase of analysis, major variables with significant main or interaction effects on log serum zinc were identified with the use of analysis of variance models. The major variables included in the model were age (in y), sex, time of the day of blood collection in a fasting or nonfasting state ("time/fasting status"), and their interaction terms. The variable "time/fasting status" was used to categorize samples as morning fasting, morning nonfasting, afternoon, or evening. "Morning samples" were those collected before 1200, "afternoon samples" were those collected between 1200 and 1800, and "evening samples" were those collected after 1800. A subset of 5903 adult participants aged =" BORDER="0"> 20 y was requested to fast before the morning blood collection for the assessment of blood triacylglycerol. Of the subjects in this subset, those who reported that their last meal was eaten =" BORDER="0"> 8 h before the blood collection were considered to be in a fasting state; these samples are referred to as "morning fasting" samples. Samples from subjects who had blood drawn in the morning but who were not requested to fast are referred to as "morning nonfasting" samples; subjects who were not asked to fast were not questioned about the time of their last meal, and it is possible that some of the subjects arrived in a fasting state of their own accord.

To achieve a parsimonious model, interaction terms were removed in a stepwise fashion, as long as no higher-order interaction involving the same terms remained in the model. For each of the 3 major variables, log serum zinc was predicted from the resulting model, and the antilogarithm was calculated. Smoothed curves for the 50th percentile of serum zinc concentration by age were created for each of the significant major variables by entering age in years as a 4th-order polynomial function. The same procedures described above were carried out for the SD of log serum zinc to examine potential differences in the variability of data among the 3 major variables.

For the second phase of analysis, all other relevant variables derived from the survey were reviewed to identify factors known or suspected to affect serum zinc concentration, independent of the zinc status of the subjects (ie, present or recent pregnancy or lactation; use of oral contraceptives, steroids, or other hormones; low serum albumin concentration; elevated or low white blood cell counts; diabetes; diarrhea; anemia; and cigarette smoking). Those variables with a significant association with log serum zinc concentration were identified by using analysis of covariance, with the major confounding variables identified in the first phase of analysis (ie, sex, age, and time/fasting status) being controlled for. Data for subjects with factors having a significant relation with serum zinc concentration were removed before further analysis.

The sample 2.5th percentile was calculated numerically at each age (in y), borrowing data from the 2 surrounding ages to avoid bias due to small sample size; data were smoothed following the same procedures as used for the 50th percentile curves. Age groups were then formed in 5-y intervals, from 0–4 to 70–74 y. Because serum zinc data were available only for children aged =" BORDER="0"> 3 y, the first age group represents data for children 3–4 y of age only. The midpoint of the 2.5th percentile for each age group was determined, and curves were developed for each sex and time/fasting status group.

The need to establish separate cutoffs based on the major variables and by age group was then assessed. It was reasoned that the absolute difference in serum zinc concentration occurring among age groups beyond which a separate cutoff should be established should exceed a moderate level of analytic measurement error for serum zinc concentration. Flame atomic absorption spectrophotometry is a common analytic method for measuring zinc in biological samples. With this analytic method, a CV < 1% is possibly achievable, a CV < 5% is reasonably achievable, and a CV < 10% is expected to be achieved (16). On the basis of the overall geometric mean serum zinc concentration for the NHANES data set (86 µg/dL), a CV of 5% would allow differences of 4.3 µg Zn/dL to be measured with confidence that the difference does not occur because of measurement error. This value was thus used to define meaningful differences in serum zinc concentration between the various groups.


RESULTS  
Of the 14 770 subjects for whom serum zinc data were available, data for 1307 were excluded from further analysis, largely because of inadequate information on the duration of fasting in the subset of 5903 subjects who were requested to fast before their blood was drawn. The reasons for these exclusions and the number of subjects in each category are summarized in Figure 1. The overall mean and the effect of the 3 major variables on serum zinc concentrations are summarized in Table 1.


View larger version (21K):
FIGURE 1. . Summary of the number of subjects included and excluded from the analysis of serum zinc concentration, derived from an analysis of data from the second US National Health and Nutrition Examination Survey, 1976–1980. 1Refer to the text for specific criteria. 2113 subjects were excluded on the basis of multiple criteria. 3Samples were collected before 1200 in subjects aged =" BORDER="0"> 20 y who had fasted for =" BORDER="0"> 8 h. 4Samples were collected before 1200 from subjects who were not requested to fast and who were assumed to have eaten before the collection. 5Samples were collected in the afternoon between 1200 and 1800. 6Samples were collected in the evening after 1800. WBC, white blood cell.

 

View this table:
TABLE 1 . Adjusted serum zinc concentration in subgroups of participants with factors known to affect serum zinc concentration independently of zinc status  
Effect of major confounding variables on serum zinc concentrations
Sex
Serum zinc concentrations differed significantly between males (88.4 ± 0.2 µg/dL) and females (83.3 ± 0.2 µg/dL; P < 0.0001). The data points and smoothed 50th percentile curves of serum zinc by sex and year of age are shown in Figure 2. During childhood, males had lower serum zinc concentrations than did females, but this reversed in late childhood (10 y of age) when the concentrations in males began to exceed those of females. Throughout late adulthood (40 y of age and older), the magnitude of sex differences decreased with age and all but disappeared after 60 y of age. Differences between males and females were more pronounced in the morning samples than in the afternoon or evening samples.


View larger version (12K):
FIGURE 2. . Percentiles (50th) of serum zinc concentration by age and sex (, males; •, females) derived from an analysis of data from the second US National Health and Nutrition Examination Survey, 1976–1980.

 
Age
Age was significantly associated with serum zinc concentration (P < 0.0001) (Figure 2). Serum zinc concentrations were lowest in young children, increased steadily with age, peaked between 18 and 25 y of age, decreased slowly during adulthood, and dropped off after 65–70 y of age.

Time of day
The time of day that blood samples were drawn had a significant effect on serum zinc concentrations (P < 0.0001), such that serum zinc was higher in the morning samples than in the afternoon or evening samples. This trend was less pronounced in subjects 60 y of age and older, ie, serum zinc in the morning samples decreased to meet the afternoon and evening concentrations. The evening and afternoon samples were similar except for those from adults 40 y of age and older, after which time serum zinc in the evening samples began to exceed the values in the afternoon samples. Data points and smoothed curves for the 50th percentile of serum zinc concentration by time of day of blood collection and year of age are shown in Figure 3.


View larger version (20K):
FIGURE 3. . Percentiles (50th) of serum zinc concentration by age and time of day of blood sample collection and fasting status, derived from an analysis of data from the second US National Health and Nutrition Examination Survey, 1976–1980. Data for each time of day and fasting status group are shown as follows: , morning fasting (=" BORDER="0"> 8 h); , morning nonfasting; •, afternoon nonfasting; , evening nonfasting. See Subjects and Methods for details.

 
Morning fasting compared with morning nonfasting samples
Fasting samples were derived for a subset of 5904 adult subjects (> 20 y of age) only, and most of the fasting samples were collected in the morning; therefore, only these samples were included (Figure 3). The serum zinc concentration was greater in the morning fasting samples than in the morning nonfasting samples, although the magnitude of this difference varied with age. For young adults (20–30 y of age), there was little difference in serum zinc concentrations between the morning fasting and the morning nonfasting samples, but this difference increased steadily with age until 60–65 y of age.

The CV for serum zinc concentration is used as a measure of dispersion of this variable in the present analysis. Because serum zinc is approximately log-normally distributed, the SD of the log-transformed variable is related to the CV of the untransformed variable. The CV for serum zinc concentration differed significantly by age (P = 0.0001), sex (P = 0.0002), and time/fasting status (P = 0.015). The CV for serum zinc was greater in children (14.5% at 7 y of age, ie, the median age of those < 10 y of age) than in adolescents and adults (13.1% at 34 y, ie, the median age of those =" BORDER="0"> 10 y) and was slightly greater in men (15.4%) than in women (14.3%). The CVs for time/fasting status were 14.5% for morning fasting, 14.6% for morning nonfasting, 15.8% for afternoon, and 14.2% for evening.

Effect of other potentially confounding variables on serum zinc concentrations
After identification of the abovementioned significant variables, additional characteristics found to be associated with serum zinc concentration but likely to be independent of the subject’s zinc status were as follows: low serum albumin (< 3.5 g/dL); high white blood cell count (> 11.5 x 109/L); current pregnancy or lactation (females aged 14–42 y only); current use of oral contraceptives (females aged =" BORDER="0"> 13 y), steroids (=" BORDER="0"> 14 y), or other hormones (=" BORDER="0"> 17 y); and current diarrhea (3–9 y). Current diarrhea had a significant interaction with sex, such that only boys had a significantly lower serum zinc concentration. The numbers of subjects excluded from further analyses for each of these variables are summarized in Figure 1. The adjusted mean serum zinc concentrations for each of the potentially confounding variables and the resultant P values, tested in an analysis of covariance model, are summarized in Table 1. Other variables tested but found not to have a significant effect (P > 0.05) on serum zinc concentration were as follows: low white blood cell count (< 3.4 x 109/L), presence of anemia (self-reported), recent pregnancy or lactation (past 12 mo, but not current), self-reported diabetes, and cigarette smoking (=" BORDER="0"> 12 y only).

An assessment of the smoothed 2.5th percentile data for the 11 857 remaining subjects, by 5-y age groups, indicated that meaningful differences (ie, > 4.3 µg/dL) in serum zinc concentration existed between sexes, between morning fasting and morning nonfasting samples, and between afternoon and morning nonfasting samples but not between afternoon and evening samples. Although the magnitude of sex differences in the 2.5th percentile data varied with age, these differences exceeded 4.3 µg/dL through most of adulthood (30–49 y of age). Therefore, it is reasonable to consider separate reference cutoffs for males and females. For both males and females, morning fasting and morning nonfasting samples differed by > 4.3 µg/dL from =" BORDER="0"> 40–45 y of age, whereas differences between morning nonfasting and afternoon samples differed substantially for all age groups. Because differences between afternoon and evening samples were not substantial for any age group, these data were combined. On the basis of these observations, separate reference curves for the 2.5th percentiles were developed for each sex and, within each sex, for morning fasting, morning nonfasting, and combined afternoon and evening samples (Figure 4, A and B).


View larger version (17K):
FIGURE 4. . Percentiles (2.5th) of serum zinc concentration for males (A) and females (B) aged 3–74 y, by age and time of day of blood sample collection and fasting status, derived from the second US National Health and Nutrition Examination Survey, 1976–1980. Symbols represent the midpoint for 5-y age intervals. Curves were fitted by using a fourth-order polynomial function for age in years. Data for each time of day and fasting status group are shown as follows: , morning fasting (=" BORDER="0"> 8 h); , morning nonfasting; •, afternoon and evening combined. See Subjects and Methods for details.

 
Finally, for each of these reference curves, the differences between age groups were assessed to determine where it was justified to establish separate cutoff values. Starting at the tail ends of each curve, where the cumulative difference in serum zinc concentrations between midpoints of adjacent age groups exceeded 4.3 µg/dL, a separate cutoff was derived. The suggested lower cutoffs for serum zinc concentration by age group, sex, and time/fasting status are given in Table 2.


View this table:
TABLE 2 . Percentiles (2.5th) of serum zinc concentration based on age group, sex, and fasting status and time of day of blood collection (time/fasting status)1  
It was of interest to examine serum zinc data separately for pregnant women. The NHANES II data set provided results for 99 women during pregnancy; however, only 61 valid data points remained after the exclusion of subjects who also had other characteristics found to affect serum zinc concentration. Time/fasting status was not found to significantly affect mean serum zinc concentrations in pregnant women, and all groups were combined to attain sufficient sample size for further analyses. The 50th percentile of serum zinc concentrations, by month of pregnancy, is given in Figure 5. Mean serum zinc decreased steadily throughout pregnancy from 72 ± 2.7 µg/dL during the first month to 61 ± 1.7 µg/dL during the ninth month. Although this sample size was not adequate to derive a 2.5th percentile with reliability for each month of pregnancy, an analysis of variance of log serum zinc by trimester indicated that the 2.5th percentile for the first trimester was 56 µg/dL; the 2.5th percentile for the second and third trimesters did not differ significantly, and the pooled value was 50 µg/dL (Table 3).


View larger version (9K):
FIGURE 5. . Median serum zinc concentration by month of pregnancy, derived from an analysis of data from the second US National Health and Nutrition Examination Survey, 1976–1980.

 

View this table:
TABLE 3 . Tentatively proposed lower cutoffs (2.5th percentile) for the assessment of serum zinc concentration in pregnant women or women using oral contraceptive agents (15–44 y of age)1  
Given the relatively large number of women in the survey who were currently using oral contraceptive agents, it also seemed appropriate to assess the 2.5th percentiles for this group. Time/fasting status was a significant factor, and the 2.5th percentiles were derived for each of these groups following the same method as described above for determining age- and sex-group cutoffs for the included subjects. The results for oral contraceptive users are presented in Table 3. Because the 2.5th percentiles differed by > 4.3 µg/dL between the afternoon and evening blood samples, separate lower cutoffs were derived for each of these time groups. Although data were available for women > 45 y of age, 2.5th percentiles are not given for these women. Except for the morning nonfasting group, cumulative differences in serum zinc concentration between the 5-y age groups were > 4.3 µg/dL after 40–44 y of age, which, according to our method, indicates that a separate lower cutoff should be set. However, the number of older women who used oral contraceptives was small (n = 10), and the data did not follow the expected pattern for time/fasting status. Therefore, a single 2.5th percentile for the evening samples is presented, which includes data from oral contraceptive users aged 15–39 y.


DISCUSSION  
We reanalyzed the NHANES II data on serum zinc concentration to develop reference cutoffs for population assessment based on the 2.5th percentile, after we controlled for factors that affect serum zinc deficiency independent of zinc status. Specific cutoffs were developed based on sex, age, and time/fasting status. Tentative lower cutoffs were also proposed for pregnant women and for women using oral contraceptives.

The difference in serum zinc concentrations between males and females was equivalent to 5.6% of the overall mean serum zinc concentration for all participants, and the difference in serum zinc concentrations between nonfasting children (3–9 y of age) and nonfasting adolescents and adults (=" BORDER="0"> 10 y of age) was 4.3%. In comparison, differences introduced by fasting state (morning fasting compared with morning nonfasting) and time of day (morning compared with afternoon) were 7.3% and 9.5%, respectively. Although the differences introduced by age and sex were of a somewhat lesser magnitude than were those introduced by time/fasting status, they were significant and substantial; therefore, all 4 variables should be considered when setting lower cutoffs for interpreting serum zinc status.

The diurnal variation in circulating zinc concentrations is largely a result of metabolic changes after meal consumption, although some variation may occur as a result of normal circadian variations in metabolism (17, 18). Meal consumption results in a decrease in serum zinc concentrations, which is cumulative with repeated meals (17, 19), whereas overnight and daytime fasting result in increased circulating zinc concentrations (17). Differences in serum zinc concentration by sex (20–22) and by age (20, 23) were noted previously. Possible reasons for these age- and sex-based differences include differences in serum albumin concentrations and in lean body mass. Concentrations of albumin and zinc in serum were strongly correlated, because 80% of zinc in the circulation is bound to albumin. In the present analysis, changes in serum albumin concentration with age explained most of the variability in serum zinc concentrations in adults aged =" BORDER="0"> 20 y and 50% of the variability among those aged < 20 y. Differences in serum albumin concentrations explained nearly 50% of the difference in serum zinc concentrations between sexes. Estrogen and progesterone are associated with lower serum zinc concentrations in women when these hormones are at their highest concentrations during the ovulatory and luteal phases of the menstrual cycle (24). Data from Pinna et al (25) suggest that the size of the rapidly exchangeable zinc pool, of which serum zinc is a part, is directly associated with lean body mass (r = 0.91, P < 0.01), which may partly explain the lower serum zinc concentrations found in women and the elderly than in men.

Data were removed for subjects with conditions that were known to affect serum zinc concentration but that cannot necessarily be attributed to a change in zinc status. As in the previous analyses of NHANES II survey results, data from subjects with low serum albumin concentrations, subjects with elevated white blood cell counts, and current users of oral contraceptives were eliminated from the analysis because of significantly lower serum zinc concentrations (Table 1). Severe decreases in serum albumin occur with conditions such as cirrhosis and protein-energy malnutrition (13). With concurrent infections, as indicated by high white blood cell counts, the noted decrease in serum zinc concentrations (26) probably occurs because of the release of cytokines, which stimulates hepatic metallothionein synthesis and leads to hepatic sequestration of circulating zinc (27, 28). C-reactive protein, an acute phase response factor, was not measured in NHANES II, but it may also be used to identify subjects with concurrent infections and to control for this confounding variable in the analysis of serum zinc results (29). Use of oral contraceptive agents has been documented in other studies to affect serum zinc concentration (30, 31).

Unlike the previous analysis, we removed data for subjects who were using steroids or other hormones because of the observed effects of physiologic or pharmacologically induced changes in hormone or steroid concentrations on serum zinc concentration (24, 30–32). Finally, subjects with a current episode of diarrhea were found to have significantly lower serum zinc concentrations than were other participants and, therefore, were also removed. Acute diarrhea may result in large losses of endogenous zinc through the intestine (33); therefore, serum zinc concentrations during diarrhea may reflect acute changes in zinc metabolism and not necessarily the true zinc status. These conditions should be considered as possible confounding factors in the analysis of serum zinc status in populations, and associated data may be excluded or controlled for during analysis.

In the current analysis, we found no significant differences in serum zinc concentration among the women who had been pregnant or lactating within 1 y before the survey was conducted (P > 0.05; analysis of covariance); therefore, unlike in the previous analysis of these data (12), we did not eliminate these data from consideration. Data for women who were currently pregnant or lactating were, however, analyzed separately. Serum zinc concentrations decreased during pregnancy as a consequence of blood volume expansion and possibly because of hormonal changes. In the current analysis, the decrease in serum zinc concentration appears to have been largely due to hemodilution, because the ratio of serum zinc to albumin, as a marker of change in blood volume, was relatively constant by month of pregnancy and did not differ significantly between pregnant and nonpregnant women (P = 0.23). A longitudinal study of changes in plasma zinc concentrations during pregnancy among apparently healthy US women consuming adequate amounts of zinc, reported mean plasma zinc concentrations in the third (71 µg/dL; n = 9) and ninth (57 µg/dL; n = 16) months of pregnancy that were comparable with the respective median serum zinc concentrations from NHANES II (76 and 63 µg/dL, respectively) (34). The 90% confidence limits in the longitudinal study for the second and ninth months of gestation (54 and 40 µg/dL, respectively) were also similar to the 2.5th percentiles derived in the current analysis for women during the first and second and third trimesters combined (55 and 46 µg/dL, respectively); the latter values can be used tentatively as lower cutoffs for pregnancy until further reference data are available.

Unfortunately, the number of lactating women for whom serum zinc data were available and were not excluded for other reasons was small (n = 23); therefore, it was not possible to derive reliable estimates of the 2.5th percentiles for this group. Until further reference data become available for lactation, the lower cutoffs for nonpregnant women may be used with the recognition that the proportion of lactating women with low serum zinc concentrations may be overestimated.

Because women of childbearing age are generally at high risk of nutritional deficiencies, they are often oversampled in representative surveys, and many of them use oral contraceptive agents. It may not be desirable to exclude from assessments the serum zinc data from oral contraceptive users or appropriate to compare their results with lower cutoffs for nonusers of oral contraceptives. Therefore, tentative lower cutoffs for serum zinc for oral contraceptive users are presented, albeit with the precaution that the effects of oral contraceptives on serum zinc may vary as a result of different formulations of these hormones.

Serum zinc concentrations were not measured in children < 3 y of age in NHANES II. Two smaller studies collected serum zinc data with the intent of establishing pediatric reference values, including this age group (23, 35); however, only one of the studies (23) disaggregated the data for children < 3 y of age and did not control for time/fasting status (35). The 2.5th percentile reported for the 9–23-mo-old Australian children was 59 µg/dL (n = 132), and that for the 3–5-y-old children was 52 µg/dL (n = 226). These values are intermediate to those found in the NHANES II survey for blood samples collected in the morning and afternoon from children 0–5 y of age (Table 3). Thus, until further reference data are available for children < 3 y of age, it appears appropriate to use the lower cutoffs for the 0–5-y age group presented in Table 3.

Serum zinc concentration is not considered to be a reliable indicator to diagnose mild or moderate zinc deficiency in individual persons. Serum zinc is fairly well maintained within a normal range during short-term zinc depletion because of efficient homeostatic mechanisms and, therefore, may show measurable changes only when zinc depletion is prolonged or severe (36). Nonetheless, measurable differences in serum zinc concentration have been observed to occur in groups or populations in response to changes in dietary zinc intakes and clinical conditions associated with zinc deficiency. For example, serum zinc concentrations vary on the basis of differences in total dietary intakes or changes in the likely absorption of the forms of dietary zinc among groups of subjects (37–39). Median serum zinc concentrations in women during pregnancy were found to predict infant birth weight in response to zinc supplementation (6). A low serum zinc concentration (< 54.9 µg/dL) was shown to predict an increased risk of diarrhea among children in India (10). Also, in a previous meta-analysis of the effect of zinc supplementation on growth in children, the initial mean serum zinc concentration was negatively correlated with the magnitude of the growth response (11). Although this relation was not observed in an updated meta-analysis (2), it was noted that studies of severely malnourished children included in the previous meta-analysis were omitted in the updated version, so it is possible that the relation was masked because of a smaller range of mean serum zinc values available among the studies included in the updated analysis. Therefore, it appears that serum zinc is a useful indicator of population zinc status, such that a high proportion of individual persons with low serum zinc concentrations suggests an elevated risk of zinc deficiency within the population.

The 2.5th percentiles for serum zinc concentration presented in Table 1 may be simplified for convenient use as lower cutoffs in survey assessments, as summarized in Table 4. Although the lower cutoffs derived in the present study for children and nonpregnant women by time/fasting status do not differ markedly from those suggested previously, cutoffs derived for men were substantially higher in the morning samples. If the previously suggested lower cutoffs were applied to the assessment of zinc status in men, the prevalence of zinc deficiency in men would be somewhat underestimated.


View this table:
TABLE 4 . Suggested lower cutoffs (2.5th percentile) for the assessment of serum zinc concentration in population studies1  
In conclusion, we have presented suggested lower cutoffs for the assessment of risk of zinc deficiency in human populations based on serum zinc concentration, taking into account 4 major confounding variables: age, sex, time of day of blood sampling, and fasting state of the subjects. As population-based health and nutrition surveys in at-risk areas begin to include biochemical assessments of zinc status, each of the abovementioned variables should be considered in the design of the survey and during data interpretation. Several other factors associated with significantly lower serum zinc concentrations and presumably independent of zinc status were also identified, and these should be treated as confounding variables when they occur.


ACKNOWLEDGMENTS  
We acknowledge the assistance of the Steering Committee of the International Zinc Nutrition Consultative Group (KH Brown, JA Rivera, ZA Bhutta, RS Gibson, JC King, M Ruel, B Sandström, and E Wasantwisut) for providing advice on the presentation of results.

CH and KHB developed the conceptual framework of the analysis, and JMP performed and provided advice on all statistical analyses. All authors assisted in the interpretation and presentation of results. The manuscript was drafted by CH with contributions by KHB and JMP.


REFERENCES  

  1. Brown KH, Wuehler SE, Peerson JM. The importance of zinc in human nutrition and estimation of the global prevalence of zinc deficiency. Food Nutr Bull 2001;22:113–25.
  2. Brown KH, Peerson JM, Rivera J, Allen LH. Effect of supplemental zinc on the growth and serum zinc concentrations of pre-pubertal children: a meta-analysis of randomized, controlled trials. Am J Clin Nutr 2002;75:1602–71.
  3. Zinc Investigators’ Collaborative Group. Prevention of diarrhea and pneumonia by zinc supplementation in children in developing countries: pooled analysis of randomized controlled trials. J Pediatr 1999;135:689–97.
  4. Penland JG, Sandstead HH, Alcock NW, et al. A preliminary report: effects of zinc and micronutrient repletion on growth and neuropsychological function of urban Chinese children. J Am Coll Nutr 1997;16:268–72.
  5. Bentley ME, Caulfield LE, Ram M, et al. Zinc supplementation affects the activity patterns of rural Guatemalan infants. J Nutr 1997;127:1333–8.
  6. Goldenberg RL, Tamura T, Neggers Y, et al. The effect of zinc supplementation on pregnancy outcome. JAMA 1995;274:463–8.
  7. Merialdi M, Caulfield LE, Zavaleta N, Figueroa A, DiPietro JA. Adding zinc to prenatal iron and folate tablets improves fetal neurobehavioral development. Am J Obstet Gynecol 1998;180:483–90.
  8. Osendarp SJM, van Raaij JMA, Darmstadt GL, Baqui AH, Hautvast JG, Fuchs GJ. Zinc supplementation during pregnancy and effects on growth and morbidity in low birthweight infants: a randomized placebo controlled trial. Lancet 2001;357:1080–5.
  9. Mocchegiani E, Muzzioli M, Giacconi R. Zinc and immunoresistance to infection in aging: new biological tools. Trends Pharmacol Sci 2000;21:205–8.
  10. Bahl R, Bhandari N, Hambidge KM, Bahn MK. Plasma zinc as a predictor of diarrheal and respiratory morbidity in children in an urban slum setting. Am J Clin Nutr 1998;68(suppl):414S–7S.
  11. Brown KH, Peerson JM, Allen LH. Effect of zinc supplementation on children’s growth: a meta-analysis of intervention trials. Bibl Nutr Dieta 1998;l54:76–83.
  12. Pilch SM, Senti FR. Assessment of the zinc nutritional status of the U.S. population based on data collected in the second National Health and Nutrition Examination Survey, 1976–1980. Bethesda, MD: Life Sciences Research Office, Federation of American Societies for Experimental Biology, 1984.
  13. Solomons NW. On the assessment of zinc and copper nutriture in man. Am J Clin Nutr 1979;32:856–71.
  14. McDowell A, Engel A, Massey JT, Maurer KR. Plan and operation of the second National Health and Nutrition Examination Survey, 1976–1980. Vital Health Stat 1 1981;15:1–144.
  15. Gunter EW, Turner WE, Neese JW, Bayse DD. Laboratory procedures used by the Clinical Chemistry Division, Centers for Disease Control, for the Second Health and Nutrition Examination Survey (HANES II) 1976–1980. Atlanta: U.S. Department of Health and Human Services, 1985.
  16. World Health Organization. Trace elements in human health and nutrition. Geneva: World Health Organization, 1996.
  17. Wallock LM, King JC, Hambidge KM, English-Westcott JE, Pritts J. Meal-induced changes in plasma, erythrocyte, and urinary zinc concentrations in adult women. Am J Clin Nutr 1993;58:695–701.
  18. Guillard O, Piriou A, Gombert J, Reiss D. Diurnal variations of zinc, copper and magnesium in the serum of normal fasting adults. Biomedicine 1979;31:193–4.
  19. Goode HF, Robertson DAF, Kelleher J, Walker BE. Effect of fasting, self-selected and isocaloric glucose and fat meals and intravenous feeding on plasma zinc concentrations. Ann Clin Biochem 1991;28:442–5.
  20. Grandjean P, Nielsen GD, Jorgensen PJ, Horder M. Reference intervals for trace elements in blood: significance of risk factors. Scand J Clin Lab Invest 1992;52:321–37.
  21. Helgeland K, Haider T, Jonsen J. Copper and zinc in human serum in Norway. Scand J Clin Lab Invest 1982;42:35–9.
  22. Garcia MJ, Alegria A, Barbera R, Farre R, Lagarda MJ. Selenium, copper and zinc indices of nutritional status. Influence of sex and season on reference values. Biol Trace Elem Res 2000;73:77–83.
  23. Lockitch G, Halstead AC, Wadsworth OL, Quigley G, Reston L, Jacobson B. Age- and sex-specific pediatric reference intervals and correlations for zinc, copper, selenium, iron, vitamins A and E, and related proteins. Clin Chem 1988;34:1625–8.
  24. Deuster PA, Dolev E, Bernier LL, Trostmann UH. Magnesium and zinc status during the menstrual cycle. Am J Obstet Gynecol 1987;157:964–8.
  25. Pinna K, Woodhouse LR, Sutherland B, Shames DM, King JC. Exchangeable zinc pool masses and turnover are maintained in healthy men with low zinc intakes. J Nutr 2001;131:2288–94.
  26. Singh A, Smoak BL, Patterson KY, LeMay LG, Veillon C, Deuster PA. Biochemical indices of selected trace minerals in men: effect of stress. Am J Clin Nutr 1991;53:126–31.
  27. Schroeder JJ, Cousins RJ. Interleukin 6 regulates metallothionein gene expression and zinc metabolism in hepatocyte monolayer cultures. Proc Natl Acad Sci U S A 1990;87:3137–41.
  28. Rofe AM, Philcox JC, Coyle P. Trace metal, acute phase and metabolic response to endotoxin in metallothionein-null mice. Biochem J 1996;314:793–7.
  29. Brown KH. Effect of infections on plasma zinc concentration and implications for zinc status assessment in low-income countries. Am J Clin Nutr 1998;68(suppl):425S–9S.
  30. Halsted JA, Hackley BM, Smith JC Jr. Plasma zinc and copper in pregnancy and after oral contraceptives. Lancet 1968;2:278–9.
  31. Prasad AS, Oberleas D, Lei KY, Moghissi KS, Stryker JC. Effect of oral contraceptive agents on nutrients. 1. Minerals. Am J Clin Nutr 1975;28:377–84.
  32. Flynn A, Pories WJ, Strain WH, Hill OA Jr, Fratianne RB. Rapid serum-zinc depletion associated with corticosteroid therapy. Lancet 1971;2:1169–72.
  33. Castillo-Duran C, Vial P, Uauy R. Trace mineral balance during acute diarrhea in infants. J Pediatr 1988;113:452–7.
  34. Hambidge KM, Krebs NF, Jacobs MA, Favier A, Guyette L, Ikle DN. Zinc nutritional status during pregnancy: a longitudinal study. Am J Clin Nutr 1983;37:429–42.
  35. Karr M, Mira M, Causer J, et al. Age-specific reference intervals for plasma vitamins A, E and beta-carotene and for serum zinc, retinol-binding protein and prealbumin for Sydney children aged 9–62 months. Int J Vitam Nutr Res 1997;67:432–6.
  36. King JC. Assessment of zinc status. J Nutr 1990;120:1474–9.
  37. Gibson RS, Heath A-L, Prosser N, et al. Are young women with low iron stores at risk of zinc as well as iron deficiency? In: Roussel AM, Anderson RA, Favier AE, eds. Proceedings of the 10th meeting of Trace Elements in Man and Animals, Evian, France, May 2–7, 1999. New York: Kluwer Academic, 2000:323–8.
  38. Hunt JR, Matthys LA, Johnson LK. Zinc absorption, mineral balance, and blood lipids in women consuming controlled lactoovovegetarian and omnivorous diets for 8 wk. Am J Clin Nutr 1998;67:421–30.
  39. Srikumar TS, Johansson GK, Ockerman PA, Gustafsson JA, Akesson B. Trace element status in healthy subjects switching from a mixed to a lactovegetarian diet for 12 mo. Am J Clin Nutr 1992;55:885–90.
Received for publication January 15, 2003. Accepted for publication March 25, 2003.


作者: Christine Hotz
医学百科App—中西医基础知识学习工具
  • 相关内容
  • 近期更新
  • 热文榜
  • 医学百科App—健康测试工具